ABSTRACT Objective: To define the incidence of early and recurrent urinary tract infections (RUTIs) in the 12-month postoperative period following midurethral sling (MUS) operations and evaluate for risk factors. Methods: This retrospective chart review compiled all urine analyses and urine culture results within 12 months of MUS surgery on all patients in the years 2006-2012 for which data were available. All coincident risk factors were tabulated. Statistical analysis was performed using SAS v 9.2 (SAS Institute, Cary, North Carolina). Results: 141 MUS procedures were performed in the 6-year time frame utilizing standard antibiotic prophylaxis regimens. 133 had adequate data for analysis. 10 patients (7.5% confidence intervals [CI] [3.7-12.4]) developed an acute UTI in the first 8 weeks postoperatively. 3 of 121 patients (2.3% CI [0.5-5.9]) developed RUTIs in the first year following surgery. Bivariate and multiple logistic regression analyses of the data did not reveal any risk factors for either isolated postoperative UTIs or RUTIs. Conclusions: This study documents a low incidence of both acute and RUTIs in the female population undergoing MUS operations. These results support the current recommendations for perioperative prophylactic antibiotics for anti-incontinence procedures.
INTRODUCTION
Urinary tract infections (UTIs) are the most common bacterial infections among women, amounting to 8.3 million of all office visits annually. 1 UTIs are also a common and problematic diagnosis among deployed active duty female soldiers. Reported risk factors for UTIs include sexual intercourse, age, menopausal status, bladder dysfunction with elevated postvoid residuals (PVR), catheterization, and surgery. 2, 3 Surgery for incontinence has clearly been shown to be a risk factor for acute UTIs and has been associated with recurrent UTIs (RUTIs). 3 The current literature reports a wide range of incidence of acute UTIs following anti-incontinence surgery ranging from 6% to 48% within 6 weeks of surgery. [4] [5] [6] [7] The incidence of acute UTIs following anti-incontinence surgery appears to have decreased with the advent of the midurethral sling (MUS) operations with the most recent large trials showing an incidence of 10%. 8 Despite the low incidence and low morbidity of this postoperative complication with either the transobturator tape (TOT) or transvaginal tape (TVT) sling operation, some surgeons have promoted a course of empiric postoperative antibiotic therapy. Recently, one research team completed a multicenter randomized controlled trial utilizing a 3-day postoperative course of nitrofurantoin vs. placebo documenting a reduction in symptomatic UTIs from 32% to 18% in the first 6 weeks postoperatively. 9 These variable results provided the impetus for us to evaluate the incidence of UTIs and RUTIs following MUS operations in our military teaching center and evaluate for potential risk factors for these postoperative complications.
METHODS
This retrospective chart review compiled inpatient and outpatient data for all patients who had undergone MUS procedures at Tripler Army Medical Center, Department of Obstetrics and Gynecology, over the course of the years 2006-2012. This study involved a retrospective review of the electronic medical record including preoperative history and physical notes, operative notes, prescriptions, and all postoperative visits including laboratory results in the first 12 months following MUS operations. A UTI was defined by clinical symptoms of urgency, frequency, or dysuria, which prompted treatment with antibiotics and was confirmed by laboratory data with a urinalysis documenting nitrites, bacteria or leukocyte esterase, or a positive urine culture. These data were placed into a Microsoft Excel spreadsheet for analysis.
Per hospital surgical admission protocol, all patients underwent a urinalysis and urine culture in the 48 hours preceding surgery. Postoperatively, patients were scheduled for two follow-up appointments in the first 8 weeks postoperatively. The initial evaluation at 1 to 2 weeks postoperatively involved a simple uroflow, after which the bladder was catheterized or bladder ultrasound was performed to assess for PVR. Patients were instructed to follow up a second time 6 to 8 weeks postoperatively. During each of these appointments, the patients were screened with a review of lower urinary 10 RUTIs were documented using the International Classification of Diseases-9 codes and urine analyses in the electronic medical record system. We included any patient in our study, who had at least one follow-up appointment in our clinic in the first 8 weeks postoperatively. Only patients who had documented visits in the military electronic medical record for a minimum of 1 year following surgery were included in the RUTI analysis.
All lab specimens were processed in accordance with Cumitech 2c Laboratory Diagnosis of Urinary Tract Infections 11 and following the guidelines from The Manual of Clinical Microbiology. 12 With catheterized specimens, cultures were counted as positive with 1,000 colony forming units. With clean-catch specimens, monocultures of 50,000 were counted as positive.
All pertinent data to include age, active duty status, weight, body mass index (BMI), type of incontinence (i.e., mixed vs. stress), concomitant surgery, complications, prophylactic antibiotics, parity, type of MUS, PVR, history of anti-incontinence surgery, as well as history of RUTIs were tabulated. Surgery was categorized as minor if the surgery only involved the MUS procedure ± anterior or posterior colporrhaphy or perineorrhaphy, and the patient was discharged the day of surgery. All surgeries to include hysterectomies, which involved an overnight stay, and operations requiring catheterization 12 hours were categorized as major. Cystoscopy was performed in all patients undergoing MUS surgery. All patients underwent a standard fill and pull protocol in the postoperative period to assess for adequate emptying. The bladder was filled with 300 mL of sterile water and the Foley was removed. If the patient was unable to void adequately based on elevated PVRs, she was either instructed on intermittent self-catheterization or had a leg bag placed depending on patient preference. These patients were treated with a daily 50 mg dose of nitrofurantoin during the interval of catheterization.
Perioperative antibiotic prophylaxis was utilized for all patients undergoing MUS surgery. All patients received intravenous prophylactic antibiotic therapy within 1 hour before incision time. For nonpenicillin-allergic patients, a first generation cephalosporin was used preoperatively and was repeated at 3 hours for extended surgeries. For penicillinallergic patients, clindamycin was utilized as a single agent. In 2009, new American College of Obstetricians and Gynecologists (ACOG) recommendations were implemented to add gentamicin as a prophylactic agent in penicillin-allergic patients. 13 Only patients who required catheterization after discharge were placed on prophylactic antibiotics for the duration of the catheterization.
Statistical analysis was performed using SAS v 9.2 (SAS Institute, Cary, North Carolina). Fisher's exact tests and c 2 tests were used to examine associations between UTI incidence and categorical variables. Multivariable logistic regression analysis was done for adjusted analyses. 95% confidence intervals for incidence rates were based on the exact binomial distribution. A significance level of 0.05 was used for all analyses.
RUTI data were only evaluated for patients with at least 1 year of follow-up. This protocol was approved by the Tripler Army Medical Center Institutional Review Board.
RESULTS
Over the course of 6 years, 141 MUS procedures were performed in the division of Urogynecology at Tripler Army Medical Center, of which 133 had adequate data for analysis. Twenty-seven (20%) were active duty patients. Of the total number, 100 (75%) of patients had two visits in the first 8 weeks postoperatively. Flow chart is presented in Figure 1 and demographic data is presented in Table I .
Ten patients (7.5% CI [3.7-12.4]) developed an acute UTI in the first 8 weeks postoperatively. Of these, 6 (4.5% CI [1.9-7.8]) were symptomatic with classic symptoms of urgency, frequency, and dysuria; and four were found with catheterized cultures on patients with minimal lower urinary tract symptoms. The uropathogens included Escherichia coli (5), Klebsiella pneumoniae (2), Enterococcus faecalis (2). One of the 10 urine cultures was not completed by the lab, but the patient had severe lower urinary tract symptoms, positive findings on urinalysis and responded to a course of antibiotics. All of the isolates were pansensitive to antibiotics. Six of these UTIs were found in patients undergoing major surgery requiring overnight hospitalization with greater than 12 hours of catheter use, and four infections were found in patients undergoing outpatient MUS operations only. Five patients had catheter use greater than 48 hours postoperatively during which they were treated with prophylactic nitrofurantoin. None of these patients had more than 7 days of UTI prophylaxis. One patient with persistent obstructive voiding postoperatively developed both acute and recurrent infections.
Among the 121 patients who had data available for 1 year following surgery, only 14 total UTIs were documented in the electronic medical record in the period between 8 weeks and 1 year postoperatively. Three patients out of 121 (2.5% CI [0.5-5.9]) developed RUTIs over the course of the first year following surgery. One of the three patients had obstructive voiding postoperatively, which was treated with an urethrolysis within 6 weeks of the initial surgery, after which, she was voiding normally. She was the only one of the three patients with RUTI who had a positive urine culture documented in the first 8 weeks postoperatively. Neither of the other patients had any significant complications with surgery or in their postoperative course. One had history of RUTIs preoperatively. The other two had no known preoperative risk factors.
Sixty-two catheterized specimens were sent to the laboratory for analysis, which accounted for 9 of the 10 documented infections in the first 8 weeks postoperatively. Three of the patients were treated based on colony counts of 1,000 colony forming units. All patients with UTIs were treated with short courses of antibiotics. Most received nitrofurantoin.
Bivariate and multiple logistic regression analysis of the data did not give any significant risk factors for either isolated postoperative UTI or RUTI. Active duty status did not confer increased risk of postoperative UTI as compared with nonactive duty females. These analyses are documented in Table II. DISCUSSION Our study documents a low incidence of both early acute postoperative UTIs (7.5%) and RUTIs (2.3%) in the female population undergoing MUS surgery at our institution. Some of the acute early UTIs with low colony counts and mild symptoms may have resolved spontaneously without antibiotic therapy. 14 Importantly, these early UTIs did not lead to significant morbidity for the patients, nor did they predispose patients to RUTIs. ACOG guidelines for preoperative antibiotic prophylaxis appear adequate in preventing UTIs following MUS in uncomplicated patients.
The incidence in our study is in line with many of the previously published studies. 6, 15, 16 Other studies, though, show a significantly higher incidence. A retrospective study reviewing Medicare data from 1999 to 2005 (1,356 patients) documented a 33% incidence of postoperative UTI. 4 The 2007 Stress Incontinence Surgical Treatment Efficacy trial (SISTEr) showed a 16% incidence of UTIs in the first 6 weeks postoperatively. One year postoperatively, 32% of patients had UTIs following Burch procedure and 48% of patients had at least one UTI after placement of fascial slings. 5 With the increasing use of the less morbid MUS procedures, the incidence of postoperative UTIs appears to have been significantly reduced. The recent Trial Of Midurethral Slings (TOMUS) showed a 10.5% incidence of acute cystitis following the placement of either the TVT or TOT in the first 6 weeks postoperatively. 8 RUTIs have also been shown in varying degrees to complicate the postoperative recovery in patients undergoing MUS surgery. Karram et al 7 report a 10.9% incidence of 2 culture proven UTIs 3 months following TVT procedures. However, only 2% of subjects in either the TOMUS or SISTEr trial met criteria for RUTIs. 15 No examined risk factor was associated with an increased risk of developing a UTI. Our case series included both minor and major procedures, and although the incidence of acute UTIs was higher in the major category, this study was not powered to detect a difference. Our incidence of postoperative UTIs with major surgery is comparable to the incidence of UTIs reported in the TOMUS trial, which excluded patients undergoing concomitant abdominal surgery. The fact that prolonged, major surgery and catheterization greater than 12 hours did not significantly increase incidence of UTIs speaks, again, to the low risk of UTIs following MUS surgery and the effectiveness of perioperative prophylaxis.
Age, menopausal status, smoking, BMI, history of prior anti-incontinence surgery, and elevated PVRs 50 mL within 2 weeks of surgery did not prove to be significant factors. The data indicated a trend toward significance with increased incidence of UTIs seen with TVT vs. TOT and PVR 50mL; however, these risk factors have not been shown to be significant with any of the previous trials. Postoperative prophylaxis was only utilized in 5 patients for a limited time and did not affect the incidence of UTIs or RUTIs. This low incidence of postoperative catheterization may also have contributed to the lower incidence of UTIs in our population as compared to the study by Jackson et al 9 in which postoperative catheterization, with a 9-fold increase in UTIs, was found to be the most significant risk factor. Curiously, medical comorbidities such as diabetes mellitus did not predispose patients to UTIs or RUTIs.
An interesting finding of our study is the poor specificity of lower urinary tract symptoms for UTIs in the first 2 weeks postoperatively. These symptoms presenting postoperatively arise from the instrumentation of the urethra and bladder during surgery and likely do not represent a UTI. Approximately 50% of patients had mild symptoms in the first 2 weeks following the procedure, which prompted catheterization; however, only 9 of 62 catheterized specimens were positive. This further explains the lower incidence of UTI in our study as compared to Jackson et al 9 who used symptoms criterion without culture to document majority of UTIs in their population. Additionally, the risk of RUTIs does not appear to be related to an early postoperative UTI. In the largest study to date, combining the results of the SISTEr and TOMUS trials, Nygaard et al 15 could only identify preoperative RUTIs as a risk factor for postoperative RUTIs.
The strengths of our study include our standard follow-up procedure with most patients being followed for two clinic visits in the first 8 weeks postoperatively. This allowed us to definitively diagnosis any acute symptomatic UTI with urinalysis and culture. Our electronic medical record system allowed for ready retrieval of notes and laboratory results, and we were thus able to follow our patients for an extended period of time following surgery and clearly define the diagnoses of UTI.
The major weakness of the study is its retrospective design. The number of subjects is small and, with the low incidence of UTIs, our study is not powered adequately to evaluate for risk factors. The subjects in this study were relatively young and healthy with very few having major comorbidities such as diabetes or prior anti-incontinence surgery, likely also contributing to the low incidence of UTIs and RUTIs. As compared to the TOMUS trial, our patients were significantly younger (46 vs. 53 years) and less likely to be menopausal (28% vs. 70%); however, in neither the TOMUS or SISTEr trial, did these factors independently increase the risk of either de novo early acute or RUTIs. These results reflect the experience at one institution with the majority of cases being performed by one surgeon. As standard technique was used for these procedures, these results should be applicable to all surgeons performing either TOT or TVT procedures in a healthy population.
CONCLUSION
This study supports the current established guidelines by both the ACOG and the American Urologic Association for use of perioperative antibiotics for MUS procedures in preventing UTIs. 17, 13 These results, as well as those of prior studies, should discourage the tendency of surgeons to use empiric courses of postoperative antibiotics for patients undergoing MUS surgery. If patients are screened preoperatively, receive appropriate perioperative antibiotics per guidelines, and have their Foley catheter expeditiously removed, the risk of UTI and RUTI appears exceedingly low and suggests that placement of a MUS does not markedly increase risk of RUTIs in the first year postoperatively. Some authors are even advocating that antibiotic prophylaxis may not be necessary in routine patients undergoing uncomplicated MUS operations without any additional procedures. 18, 19 Postoperative prophylaxis should be limited to those patients requiring postoperative catheterization. Importantly, this study also confirms the low risk of RUTIs following MUS surgery in active duty women and supports current practice that surgeons can employ the MUS techniques with limited risks of inducing major infectious morbidity for their patients.
